CPHI 2018: Arbro Pharmaceuticals showcase its patented latest product containing Curcumin at the India Pharma Week 2018 being held in the capital for the first time. The exhibition started today and will run till December 14, 2018 at the India Expo Mart, Greater Noida.
During the event, Arbro Pharmaceuticals is exhibiting its latest patented products such as the capsule aids in conditions like diabetes, heart ailments, depression and even arthritis.
Arbro Pharmaceutical said it has strong presence in exports, generic formulations, ethical range of products, institutional & government supplies as well as recognized as government approved R&D facility by Department of Science and Technology, Government of India.
The company claimed that it has come up with an innovative curcumin based product, SNEC-30 capsules. Its formulation aims to improve one’s overall health. Curcumin is essentially a bright yellow chemical in turmeric that acts as a disciplinarian in the body promoting a healthy immune response and improving overall health. It also acts as a natural anti-inflammatory. Moreover, SNEC-30 doesn’t have any side effects and offers better absorption of curcumin.
“We have formulated this one-of-a-kind product in a bid to help people improve their overall health. It is being displayed at the ongoing Pharma Week being held in the Capital. In today’s time where we are more prone to health issues because of various reasons, this curcumin based product is truly essential and utmost effective to boost our immune system,” stated Dr. Saurabh Arora, Executive Director, Arbro Pharmaceuticals.
“SNEC-30 (Self-Nano Emulsifying Curcumin 30 mg), reportedly, is by far the best curcumin supplement with rapid absorption, enabling the full potential of turmeric to keep people healthy. This does not have any side effects,” said Dr. Arora.
The company asserted that it follows the revised WHO GMP guidelines that have been certified and accredited for Good Manufacturing Practices (GMP). Company’s diverse range of products includes capsules, tablets, dry syrups, oral powders and oral liquids in different therapeutic segments and dietary supplements.
The company claimed that SNEC-30 may also help improve symptoms of depression and arthritis other than COPD, which are highly prevalent in the current times. Besides, it also helps to prevent heart disease, Alzheimer’s and even cancer.
SNEC 30 has been developed by Arbro Pharmaceuticals in association with DRDO (Defense Research & Development Organization), Jamia Hamdard University and Department of Science & Technology (DST), Government of India.